BPG is committed to discovery and dissemination of knowledge
Original Article
©The Author(s) 2001.
World J Gastroenterol. Apr 15, 2001; 7(2): 259-265
Published online Apr 15, 2001. doi: 10.3748/wjg.v7.i2.259
Figure 4
Figure 4 SB203580 treatment leads to necrosis development during cerulein pancreatitis. Animals were treated as in Figure 3. Pancreata were then removed and tissue sections HE stained for light microscopy. untreated control, cerulein alone, 30 mg/kg CEP1347 4 h prior to cerulein, 30 mg/kg CEP1347 and SB203580 prior to cerulein, and 30 mg/kg SB203580 prior to cerulein. Original magnification 50 fold (A-E). Panel F shows a higher (150-fold) magnification of panel E.


Write to the Help Desk